NCT04972448

RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

A Clinical Translational Study on the Multi-gene Assays and RecurIndex for Predicting the Breast Cancer Recurrence Risk in Cross-strait Chinese Patients With Early-stage Luminal Breast Cancer

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: Zhejiang Cancer Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: —

Summary

This study will conduct a multicenter, open, prospective clinical trial to observe the RecurIndex to assist in predicting the risk of recurrence in patients with early-stage Luminal-type breast cancer. The aim of this study is to validate the predictive effect of the RecurIndex on the risk of recurrence in women with early-stage Luminal-type breast cancer in China.

Conditions

• Breast Cancer
• Recurrence

Timeline

• Start date: 2021-07-01
• Primary completion: 2025-05-01
• Completion: 2025-11-01
• First posted: 2021-07-22
• Last updated: 2021-07-22